Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)

Jinyun Donga The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China;b Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou , China;c Zhejiang Key Lab of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Zhejiang Cancer Hospital, Hangzhou , China;d School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information

Jing Yangd School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information

Wenkai Yud School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information

Haobin Lid School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information

Maohua Caid School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information

Jing-Li Xue The First Clinical Medical College of Zhejiang, Chinese Medical University, Hangzhou, ChinaView further author information

Han-Dong Xue The First Clinical Medical College of Zhejiang, Chinese Medical University, Hangzhou, ChinaView further author information

Yun-Fu Shie The First Clinical Medical College of Zhejiang, Chinese Medical University, Hangzhou, ChinaView further author information

Xiaoqing Guana The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China;b Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou , China;c Zhejiang Key Lab of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Zhejiang Cancer Hospital, Hangzhou , ChinaCorrespondence[email protected]
View further author information

Xiang‑Dong Chenga The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China;b Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou , China;c Zhejiang Key Lab of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Zhejiang Cancer Hospital, Hangzhou , ChinaCorrespondence[email protected]
View further author information

Jiang‑Jiang Qina The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China;b Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou , China;c Zhejiang Key Lab of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer, Zhejiang Cancer Hospital, Hangzhou , China;d School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaCorrespondence[email protected]
View further author information

show all

Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date